<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bekhterev</journal-id><journal-title-group><journal-title xml:lang="ru">Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева</journal-title><trans-title-group xml:lang="en"><trans-title>V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7053</issn><issn pub-type="epub">2713-055X</issn><publisher><publisher-name>V. M. BEKHTEREV  NATIONAL  RESEARCH  MEDICAL  CENTER  FOR  PSYCHIATRY  AND  NEUROLOGY                           OF    THE  RUSSIAN  FEDERATION   MINISTRY  OF  HEALTH</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31363/2313-7053-2025-4-2-1099</article-id><article-id custom-type="elpub" pub-id-type="custom">bekhterev-1247</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEW</subject></subj-group></article-categories><title-group><article-title>Гены-кандидаты воспаления и их роль в патогенезе шизофрении: современные научные данные</article-title><trans-title-group xml:lang="en"><trans-title>Inflammation-related genes and their role in the pathogenesis of schizophrenia: current scientific evidence</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1082-2388</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Отмахов</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Otmakhov</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Отмахов Андрей Павлович – ассистент кафедры психиатрии и психотерапии с клиникой Института медицинского образования</p><p>197341, г. Санкт-Петербург, ул. Аккуратова, д. 2</p></bio><bio xml:lang="en"><p>Andrey P. Otmakhov   </p><p>Saint Petersburg</p></bio><email xlink:type="simple">otmakhov_a@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7519-436X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бакиров</surname><given-names>Л. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Bakirov</surname><given-names>L. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бакиров Линар Рифкатович - к.м.н., доцент кафедры психиатрии, наркологии и психотерапии</p><p>450008, Республика Башкортостан, г. Уфа, ул. Ленина, д. 3</p></bio><bio xml:lang="en"><p>Linar R. Bakirov </p><p>Ufa</p></bio><email xlink:type="simple">Blr.ufa@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5618-4206</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Незнанов</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Neznanov</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Незнанов Николай Григорьевич – д.м.н., профессор, заслуженный деятель науки РФ, директор; заведующий кафедрой психиатрии и наркологии</p><p>192019, г. Санкт-Петербург, ул. Бехтерева, д. 3</p><p>197022, г. Санкт-Петербург, ул. Льва Толстого, 6-8</p></bio><bio xml:lang="en"><p>Nikolai G. Neznanov   </p><p>Saint Petersburg</p></bio><email xlink:type="simple">spbinst@bekhterev.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7148-4485</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Асадуллин</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Asadullin</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Асадуллин Азат Раилевич - д.м.н., профессор кафедры психиатрии, наркологии и психотерапии; профессор кафедры психиатрии, наркологии, психотерапии и клинической психологии</p><p>450008, Республика Башкортостан, г. Уфа, ул. Ленина, д. 3</p><p>410012, г. Саратов, ул. Большая Казачья, 112</p></bio><bio xml:lang="en"><p>Azat R. Asadullin  </p><p>Ufa</p><p>Saratov</p></bio><email xlink:type="simple">droar@yandex.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр им. В. А. Алмазова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Башкирский Государственный Медицинский Университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева; Первый Санкт-Петербургский государственный медицинский университет им. И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology; I.P. Pavlov First St. Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Башкирский Государственный Медицинский Университет; Саратовский ГМУ им. В. И. Разумовского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University; Saratov State Medical University named after V.I. Razumovsky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>10</day><month>01</month><year>2026</year></pub-date><volume>59</volume><issue>4-2</issue><fpage>38</fpage><lpage>50</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Отмахов А.П., Бакиров Л.Р., Незнанов Н.Г., Асадуллин А.Р., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Отмахов А.П., Бакиров Л.Р., Незнанов Н.Г., Асадуллин А.Р.</copyright-holder><copyright-holder xml:lang="en">Otmakhov A.P., Bakirov L.R., Neznanov N.G., Asadullin A.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bekhterevreview.com/jour/article/view/1247">https://www.bekhterevreview.com/jour/article/view/1247</self-uri><abstract><p>Цель. Целью аналитического обзора стали поиск, анализ и обобщение данных об ассоциациях генов-кандидатов воспаления и их влиянии на патогенез и клинические проявления шизофрении. Материалы и методы. Проводился поиск оригинальных исследований, систематических обзоров литературы и мета-анализов в базах Google Scholar, PubMed и eLIBRARY.ru. Включались публикации за период с 1 января 2017 года по 31 декабря 2024 года без языковых ограничений, посвящённые генетическим аспектам воспаления в контексте шизофрении. Результаты. Обзор подтвердил значимую роль генетических ассоциаций воспаления в патогенезе шизофрении. Полиморфизмы генов, кодирующих провоспалительные и противовоспалительные молекулы (IL6, IL10, IL1B, IL28B, TNF-α, HLA, VEGF-A, NF-κB), ассоциированы с риском заболевания, клиническими проявлениями и изменениями структуры мозга. Также отмечена роль генетической регуляции воспалительных механизмов в формировании нарушений нейропластичности, проницаемости гематоэнцефалического барьера и окислительного стресса при шизофрении. Заключение. Наш обзор подтверждает значимую роль генетических ассоциаций воспалительных механизмов в патогенезе шизофрении. Наследственная предрасположенность к дисбалансу иммунного ответа может влиять на развитие, тяжесть и течение заболевания.</p></abstract><trans-abstract xml:lang="en"><p>Objective. The aim of this analytical review was to search, analyze, and summarize data on associations of inflammatory candidate genes and their effect on the pathogenesis and clinical manifestations of schizophrenia. Materials and Methods. A comprehensive search was conducted for original research articles, systematic reviews, and meta-analyses in the databases Google Scholar, PubMed, and eLIBRARY.ru. The inclusion criteria encompassed publications from January 1, 2017, to December 31, 2024, without language restrictions, focusing on the genetic aspects of inflammation in the context of schizophrenia. Results. The review confirmed the significant role of inflammatory genetic associations in the pathogenesis of schizophrenia. Polymorphisms in genes encoding pro- and anti-inflammatory molecules (IL6, IL10, IL1B, IL28B, TNF-α, HLA, VEGF-A, NF-κB) were found to be associated with disease risk, clinical symptoms, and brain structure alterations. Additionally, genetic regulation of inflammatory processes appears to contribute to impaired neuroplasticity, blood–brain barrier permeability, and oxidative stress in schizophrenia. Conclusion. Our review highlights the critical role of genetic associations related to inflammatory mechanisms in the pathogenesis of schizophrenia. A hereditary predisposition to immune response imbalance may influence the development, severity, and course of the disorder.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>шизофрения</kwd><kwd>биомаркеры</kwd><kwd>воспаление</kwd><kwd>иммунитет</kwd><kwd>оксидативный стресс</kwd><kwd>генетическая предрасположенность к заболеванию</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Schizophrenia</kwd><kwd>Biomarkers</kwd><kwd>Inflammation</kwd><kwd>Immunity</kwd><kwd>Oxidative Stress</kwd><kwd>Genetic Predisposition to Disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Абдрахманова А.Е., Гильманов А.Ж., Галеева Е.Х., Ефремов И.С., Асадуллин А.Р. Нейровоспаление и воспалительные маркеры в периферической крови при тревожных и депрессивных расстройствах (обзор литературы). Психическое здоровье. 2022;17(6):55-64. https://doi.org/10.25557/2074-014X.2022.06.55-64</mixed-citation><mixed-citation xml:lang="en">Abdrakhmanova AE, Gilmanov AZh, Galeeva EKh, Efremov IS, Asadullin AR. Neuroinflammation and inflammatory markers in peripheral blood in anxiety and depressive disorders (literature review). Psikhicheskoe zdorov'e. 2022;17(6):55-64. (In Russ.). https://doi.org/10.25557/2074-014X.2022.06.55-64</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Голимбет В.Е, Клюшник Т.П. Молекулярно-генетический и иммунологический аспекты формирования психопатологических симптомов при шизофрении. Журнал неврологии и психиатрии имени С.С. Корсакова. 2022;122(10):66-71. https://doi.org/10.17116/jnevro202212210166</mixed-citation><mixed-citation xml:lang="en">Golimbet VE, Klyushnik TP. Molecular-genetic and immunological aspects of the formation of psychopathological symptoms in schizophrenia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2022;122(10):66-71. (In Russ.). https://doi.org/10.17116/jnevro202212210166</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Михайлова ВА, Плакунова ВВ, Лежейко ТВ, Колесина НЮ, Голимбет ВЕ. Связь полиморфизма rs1800629 гена фактора некроза опухолей альфа с субдоменами негативных симптомов шизофрении. Медицинская генетика. 2022;21(8):20-22. https://doi.org/10.25557/2073-7998.2022.08.20-22</mixed-citation><mixed-citation xml:lang="en">Mikhailova VA, Plakunova VV, Lezheiko TV, Kolesina NYu, Golimbet VE. The relationship between tnf-α gene polymorphism rs1800629 and negative symptoms factors in schizophrenia. Meditsinskaya genetika. 2022;21(8):20-22. (In Russ.). https://doi.org/10.25557/2073-7998.2022.08.20-22</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmad SF, Zoheir KMA, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, et al. Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism. Mol Neurobiol. 2017;54:4390–4400. https://doi.org/10.1007/s12035-016-9977-0</mixed-citation><mixed-citation xml:lang="en">Ahmad SF, Zoheir KMA, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, et al. Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism. Mol Neurobiol. 2017;54:4390–4400. https://doi.org/10.1007/s12035-016-9977-0</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248-1264. https://doi.org/10.1016/j.cell.2019.01.021</mixed-citation><mixed-citation xml:lang="en">Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248-1264. https://doi.org/10.1016/j.cell.2019.01.021</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Berbers RM, van der Wal MM, van Montfrans JM, Ellerbroek PM, Dalm VA, van Hagen PM, et al. Chronically activated T-cells retain their inflammatory properties in common variable immunodeficiency. J Clin Immunol. 2021;41:1621-1632. https://doi.org/10.1007/s10875-021-01084-6</mixed-citation><mixed-citation xml:lang="en">Berbers RM, van der Wal MM, van Montfrans JM, Ellerbroek PM, Dalm VA, van Hagen PM, et al. Chronically activated T-cells retain their inflammatory properties in common variable immunodeficiency. J Clin Immunol. 2021;41:1621-1632. https://doi.org/10.1007/s10875-021-01084-6</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bishop JR, Zhang L, Lizano P. Inflammation subtypes and translating inflammation-related genetic findings in schizophrenia and related psychoses: a perspective on pathways for treatment stratification and novel therapies. Harv Rev Psychiatry. 2022;30(1):59-70. https://doi.org/10.1097/HRP.0000000000000321</mixed-citation><mixed-citation xml:lang="en">Bishop JR, Zhang L, Lizano P. Inflammation subtypes and translating inflammation-related genetic findings in schizophrenia and related psychoses: a perspective on pathways for treatment stratification and novel therapies. Harv Rev Psychiatry. 2022;30(1):59-70. https://doi.org/10.1097/HRP.0000000000000321</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bleich A, Brown SL, Kahn R, van Praag HM. The role of serotonin in schizophrenia. Schizophr Bull. 1988;14(2):297-315. https://doi.org/10.1093/schbul/14.2.297</mixed-citation><mixed-citation xml:lang="en">Bleich A, Brown SL, Kahn R, van Praag HM. The role of serotonin in schizophrenia. Schizophr Bull. 1988;14(2):297-315. https://doi.org/10.1093/schbul/14.2.297</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Boukouaci W, Lajnef M, Richard JR, Wu CL, Bouassida J, Rafik I, et al. HLA-E circulating and genetic determinants in schizophrenia and bipolar disorder. Sci Rep. 2021;11(1):20260. https://doi.org/10.1038/s41598-021-99732-9</mixed-citation><mixed-citation xml:lang="en">Boukouaci W, Lajnef M, Richard JR, Wu CL, Bouassida J, Rafik I, et al. HLA-E circulating and genetic determinants in schizophrenia and bipolar disorder. Sci Rep. 2021;11(1):20260. https://doi.org/10.1038/s41598-021-99732-9</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Castañeda-Cabral JL, Beas-Zárate C, Rocha-Arrieta LL, Orozco-Suárez SA, Alonso-Vanegas M, Guevara-Guzmán R, et al. Increased protein expression of VEGF-A, VEGF-B, VEGF-C and their receptors in the temporal neocortex of pharmacoresistant temporal lobe epilepsy patients. J Neuroimmunol. 2019;328:68-72. https://doi.org/10.1016/j.jneuroim.2018.12.007</mixed-citation><mixed-citation xml:lang="en">Castañeda-Cabral JL, Beas-Zárate C, Rocha-Arrieta LL, Orozco-Suárez SA, Alonso-Vanegas M, Guevara-Guzmán R, et al. Increased protein expression of VEGF-A, VEGF-B, VEGF-C and their receptors in the temporal neocortex of pharmacoresistant temporal lobe epilepsy patients. J Neuroimmunol. 2019;328:68-72. https://doi.org/10.1016/j.jneuroim.2018.12.007</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Choi KY, Choo JM, Lee YJ, Lee Y, Cho CH, Kim SH, Lee HJ. Association between the IL10 rs1800896 polymorphism and tardive dyskinesia in schizophrenia. Psychiatry Investig. 2020;17(10):1031. https://doi.org/10.30773/pi.2020.0191</mixed-citation><mixed-citation xml:lang="en">Choi KY, Choo JM, Lee YJ, Lee Y, Cho CH, Kim SH, Lee HJ. Association between the IL10 rs1800896 polymorphism and tardive dyskinesia in schizophrenia. Psychiatry Investig. 2020;17(10):1031. https://doi.org/10.30773/pi.2020.0191</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Comer AL, Carrier M, Tremblay MÈ, Cruz-Martín A. The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation. Front Cell Neurosci. 2020;14:274. https://doi.org/10.3389/fncel.2020.00274</mixed-citation><mixed-citation xml:lang="en">Comer AL, Carrier M, Tremblay MÈ, Cruz-Martín A. The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation. Front Cell Neurosci. 2020;14:274. https://doi.org/10.3389/fncel.2020.00274</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Debnath M, Berk M, Leboyer M, Tamouza R. The MHC/HLA gene complex in major psychiatric disorders: emerging roles and implications. Curr Behav Neurosci Rep. 2018;5:179-188. https://doi.org/10.1007/s40473-018-0155-8</mixed-citation><mixed-citation xml:lang="en">Debnath M, Berk M, Leboyer M, Tamouza R. The MHC/HLA gene complex in major psychiatric disorders: emerging roles and implications. Curr Behav Neurosci Rep. 2018;5:179-188. https://doi.org/10.1007/s40473-018-0155-8</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dendrou CA, Petersen J, Rossjohn J, Fugger L. HLA variation and disease. Nat Rev Immunol. 2018;18(5):325-339. https://doi.org/10.1038/nri.2017.143</mixed-citation><mixed-citation xml:lang="en">Dendrou CA, Petersen J, Rossjohn J, Fugger L. HLA variation and disease. Nat Rev Immunol. 2018;18(5):325-339. https://doi.org/10.1038/nri.2017.143</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res. 2007;93(1-3):261-265. https://doi.org/10.1016/j.schres.2007.03.022</mixed-citation><mixed-citation xml:lang="en">Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res. 2007;93(1-3):261-265. https://doi.org/10.1016/j.schres.2007.03.022</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ermakov EA, Dmitrieva EM, Parshukova DA, Kazantseva DV, Vasilieva AR, Smirnova LP. Oxidative stress‐related mechanisms in schizophrenia pathogenesis and new treatment perspectives. Oxid Med Cell Longev. 2021;2021:8881770. https://doi.org/10.1155/2021/8881770</mixed-citation><mixed-citation xml:lang="en">Ermakov EA, Dmitrieva EM, Parshukova DA, Kazantseva DV, Vasilieva AR, Smirnova LP. Oxidative stress‐related mechanisms in schizophrenia pathogenesis and new treatment perspectives. Oxid Med Cell Longev. 2021;2021:8881770. https://doi.org/10.1155/2021/8881770</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Fan X, Pristach C, Liu EY, Freudenreich O, Henderson DC, Goff DC. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res. 2007;149(1-3):267-271. https://doi.org/10.1016/j.psychres.2006.07.011</mixed-citation><mixed-citation xml:lang="en">Fan X, Pristach C, Liu EY, Freudenreich O, Henderson DC, Goff DC. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res. 2007;149(1-3):267-271. https://doi.org/10.1016/j.psychres.2006.07.011</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Fillman SG, Weickert TW, Lenroot RK, Catts SV, Bruggemann JM, Catts VS, et al. Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume. Mol Psychiatry. 2016;21(8):1090-1098. https://doi.org/10.1038/mp.2015.90</mixed-citation><mixed-citation xml:lang="en">Fillman SG, Weickert TW, Lenroot RK, Catts SV, Bruggemann JM, Catts VS, et al. Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume. Mol Psychiatry. 2016;21(8):1090-1098. https://doi.org/10.1038/mp.2015.90</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gallego JA, Blanco EA, Husain-Krautter S, Fagen EM, Moreno-Merino P, del Ojo-Jiménez JA, et al. Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis. Schizophr Res. 2018;202:64-71. https://doi.org/10.1016/j.schres.2018.07.019</mixed-citation><mixed-citation xml:lang="en">Gallego JA, Blanco EA, Husain-Krautter S, Fagen EM, Moreno-Merino P, del Ojo-Jiménez JA, et al. Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis. Schizophr Res. 2018;202:64-71. https://doi.org/10.1016/j.schres.2018.07.019</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Gandal MJ, Haney JR, Parikshak NN, Leppa V, Ramaswami G, Hartl C, et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science. 2018;359(6376):693-697. https://doi.org/10.1126/science.aad646</mixed-citation><mixed-citation xml:lang="en">Gandal MJ, Haney JR, Parikshak NN, Leppa V, Ramaswami G, Hartl C, et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science. 2018;359(6376):693-697. https://doi.org/10.1126/science.aad646</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gnanasekaran A, Kelchen MN, Brogden NK, Smith RM. Vascular endothelial growth factor (VEGF) expression and neuroinflammation is increased in the frontopolar cortex of individuals with autism spectrum disorder. 2019. https://doi.org/10.1101/627083</mixed-citation><mixed-citation xml:lang="en">Gnanasekaran A, Kelchen MN, Brogden NK, Smith RM. Vascular endothelial growth factor (VEGF) expression and neuroinflammation is increased in the frontopolar cortex of individuals with autism spectrum disorder. 2019. https://doi.org/10.1101/627083</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Golimbet V, Lezheiko T, Mikhailova V, Korovaitseva G, Kolesina N, Plakunova V, et al. A study of the association between polymorphisms in the genes for interleukins IL-6 and IL-10 and negative symptoms subdomains in schizophrenia. Indian J Psychiatry. 2022;64(5):484-488. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_212_22</mixed-citation><mixed-citation xml:lang="en">Golimbet V, Lezheiko T, Mikhailova V, Korovaitseva G, Kolesina N, Plakunova V, et al. A study of the association between polymorphisms in the genes for interleukins IL-6 and IL-10 and negative symptoms subdomains in schizophrenia. Indian J Psychiatry. 2022;64(5):484-488. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_212_22</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Halstead S, Siskind D, Amft M, Wagner E, Yakimov V, Liu Z, et al. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2023;10(4):260-271. https://doi.org/10.1016/S2215-0366(23)00025-1</mixed-citation><mixed-citation xml:lang="en">Halstead S, Siskind D, Amft M, Wagner E, Yakimov V, Liu Z, et al. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2023;10(4):260-271. https://doi.org/10.1016/S2215-0366(23)00025-1</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Haque R, Kim Y, Park K, Jang H, Kim SY, Lee H, et al. Altered distributions in circulating follicular helper and follicular regulatory T cells accountable for imbalanced cytokine production in multiple sclerosis. Clin Exp Immunol. 2021;205(1):75-88. https://doi.org/10.1111/cei.13596</mixed-citation><mixed-citation xml:lang="en">Haque R, Kim Y, Park K, Jang H, Kim SY, Lee H, et al. Altered distributions in circulating follicular helper and follicular regulatory T cells accountable for imbalanced cytokine production in multiple sclerosis. Clin Exp Immunol. 2021;205(1):75-88. https://doi.org/10.1111/cei.13596</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hayden MS, Ghosh S. NF-κB in immunobiology. Cell Res. 2011;21(2):223-244. https://doi.org/10.1038/cr.2011.13</mixed-citation><mixed-citation xml:lang="en">Hayden MS, Ghosh S. NF-κB in immunobiology. Cell Res. 2011;21(2):223-244. https://doi.org/10.1038/cr.2011.13</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Hudson ZD, Miller BJ. Meta-analysis of cytokine and chemokine genes in schizophrenia. Clin Schizophr Relat Psychoses. 2018;12(3):121-129B. https://doi.org/10.3371/csrp.humi.070516</mixed-citation><mixed-citation xml:lang="en">Hudson ZD, Miller BJ. Meta-analysis of cytokine and chemokine genes in schizophrenia. Clin Schizophr Relat Psychoses. 2018;12(3):121-129B. https://doi.org/10.3371/csrp.humi.070516</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Jacomb I, Stanton C, Vasudevan R, Powell H, O'Donnell M, Lenroot R, et al. C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Front Immunol. 2018;9:2230. https://doi.org/10.3389/fimmu.2018.02230</mixed-citation><mixed-citation xml:lang="en">Jacomb I, Stanton C, Vasudevan R, Powell H, O'Donnell M, Lenroot R, et al. C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Front Immunol. 2018;9:2230. https://doi.org/10.3389/fimmu.2018.02230</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Javitt DC. Glutamatergic theories of schizophrenia. Isr J Psychiatry. 2010;47(1):4.</mixed-citation><mixed-citation xml:lang="en">Javitt DC. Glutamatergic theories of schizophrenia. Isr J Psychiatry. 2010;47(1):4.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Jayaraman A, Htike TT, James R, Picon C, Reynolds R. TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus. Acta Neuropathol Commun. 2021;9:1-21. https://doi.org/10.1186/s40478-021-01264-w</mixed-citation><mixed-citation xml:lang="en">Jayaraman A, Htike TT, James R, Picon C, Reynolds R. TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus. Acta Neuropathol Commun. 2021;9:1-21. https://doi.org/10.1186/s40478-021-01264-w</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Jin M, Günther R, Akgün K, Hermann A, Ziemssen T. Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):5941. https://doi.org/10.1038/s41598-020-62756-8</mixed-citation><mixed-citation xml:lang="en">Jin M, Günther R, Akgün K, Hermann A, Ziemssen T. Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):5941. https://doi.org/10.1038/s41598-020-62756-8</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kadasah S, Arfin M, Rizvi S, Al-Asmari M, Al-Asmari A. Tumor necrosis factor-α and-β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia. Neuropsychiatr Dis Treat. 2017;1081-1088. https://doi.org/10.2147/NDT.S131144</mixed-citation><mixed-citation xml:lang="en">Kadasah S, Arfin M, Rizvi S, Al-Asmari M, Al-Asmari A. Tumor necrosis factor-α and-β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia. Neuropsychiatr Dis Treat. 2017;1081-1088. https://doi.org/10.2147/NDT.S131144</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kang N, Shin W, Jung S, Bang M, Lee SH. The effect of TNF-alpha polymorphism on white matter structures and memory function in patients with schizophrenia: A pilot study. Psychiatry Investig. 2022;19(12):1027. https://doi.org/10.30773/pi.2021.0326</mixed-citation><mixed-citation xml:lang="en">Kang N, Shin W, Jung S, Bang M, Lee SH. The effect of TNF-alpha polymorphism on white matter structures and memory function in patients with schizophrenia: A pilot study. Psychiatry Investig. 2022;19(12):1027. https://doi.org/10.30773/pi.2021.0326</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Kappelmann N, Khandaker GM, Dal H, Stochl J, Kosidou K, Jones PB, et al. Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: A longitudinal cohort and co-relative study. Psychol Med. 2019;49(2):295-302. https://doi.org/10.1017/S0033291718000831</mixed-citation><mixed-citation xml:lang="en">Kappelmann N, Khandaker GM, Dal H, Stochl J, Kosidou K, Jones PB, et al. Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: A longitudinal cohort and co-relative study. Psychol Med. 2019;49(2):295-302. https://doi.org/10.1017/S0033291718000831</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kaur H, Ghorai SM. Role of cytokines as immunomodulators. In: Immunomodulators and Human Health. Singapore: Springer Nature Singapore; 2022. p. 371-414. https://doi.org/10.1007/978-981-16-6379-6_13</mixed-citation><mixed-citation xml:lang="en">Kaur H, Ghorai SM. Role of cytokines as immunomodulators. In: Immunomodulators and Human Health. Singapore: Springer Nature Singapore; 2022. p. 371-414. https://doi.org/10.1007/978-981-16-6379-6_13</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kerschensteiner M, Meinl E, Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience. 2009;158(3):1122-1132. https://doi.org/10.1016/j.neuroscience.2008.09.009</mixed-citation><mixed-citation xml:lang="en">Kerschensteiner M, Meinl E, Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience. 2009;158(3):1122-1132. https://doi.org/10.1016/j.neuroscience.2008.09.009</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Kirkpatrick B, Miller BJ. Inflammation and schizophrenia. Schizophr Bull. 2013;39(6):1174-1179. https://doi.org/10.1093/schbul/sbt141</mixed-citation><mixed-citation xml:lang="en">Kirkpatrick B, Miller BJ. Inflammation and schizophrenia. Schizophr Bull. 2013;39(6):1174-1179. https://doi.org/10.1093/schbul/sbt141</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Koistinaho J, Koskuvi M, Pörsti E, Wu YC, Trontti K, McQuade A, et al. Genetic contribution to microglial activation in schizophrenia. 2022. https://doi.org/10.21203/rs.3.rs-1980131/v1</mixed-citation><mixed-citation xml:lang="en">Koistinaho J, Koskuvi M, Pörsti E, Wu YC, Trontti K, McQuade A, et al. Genetic contribution to microglial activation in schizophrenia. 2022. https://doi.org/10.21203/rs.3.rs-1980131/v1</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Korovaitseva GI, Gabaeva MV, Oleichik IV, Golimbet VE. The effect of INDEL polymorphism of the human leukocyte antigen G (HLA-G) and the season of birth on the risk of schizophrenia and its clinical features. Russ J Genet. 2021;57(2):221-226. https://doi.org/10.1134/S102279542102006X</mixed-citation><mixed-citation xml:lang="en">Korovaitseva GI, Gabaeva MV, Oleichik IV, Golimbet VE. The effect of INDEL polymorphism of the human leukocyte antigen G (HLA-G) and the season of birth on the risk of schizophrenia and its clinical features. Russ J Genet. 2021;57(2):221-226. https://doi.org/10.1134/S102279542102006X</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Kustrimovic N, Comi C, Magistrelli L, E Rasini, Legnaro M, Bombelli R, et al. Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naive and drug-treated patients. J Neuroinflammation. 2018;15:1-17. https://doi.org/10.1186/s12974-018-1248-8</mixed-citation><mixed-citation xml:lang="en">Kustrimovic N, Comi C, Magistrelli L, E Rasini, Legnaro M, Bombelli R, et al. Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naive and drug-treated patients. J Neuroinflammation. 2018;15:1-17. https://doi.org/10.1186/s12974-018-1248-8</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Lee BH, Hong JP, Hwang JA, Ham BJ, Na KS, Kim WJ, et al. Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment. Psychiatry Res. 2015;228(1):95-99. https://doi.org/10.1016/j.psychres.2015.04.020</mixed-citation><mixed-citation xml:lang="en">Lee BH, Hong JP, Hwang JA, Ham BJ, Na KS, Kim WJ, et al. Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment. Psychiatry Res. 2015;228(1):95-99. https://doi.org/10.1016/j.psychres.2015.04.020</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Leza JC, García-Bueno B, Bioque M, Arango C, Parellada M, Do K, et al. Inflammation in schizophrenia: a question of balance. Neurosci Biobehav Rev. 2015;55:612-626. https://doi.org/10.1016/j.neubiorev.2015.05.014</mixed-citation><mixed-citation xml:lang="en">Leza JC, García-Bueno B, Bioque M, Arango C, Parellada M, Do K, et al. Inflammation in schizophrenia: a question of balance. Neurosci Biobehav Rev. 2015;55:612-626. https://doi.org/10.1016/j.neubiorev.2015.05.014</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Li W, Luo Y, Xu H, Ma Q, Yao Q. Imbalance between T helper 1 and regulatory T cells plays a detrimental role in experimental Parkinson’s disease in mice. J Int Med Res. 2021;49(4):0300060521998471. https://doi.org/10.1177/030006052199847</mixed-citation><mixed-citation xml:lang="en">Li W, Luo Y, Xu H, Ma Q, Yao Q. Imbalance between T helper 1 and regulatory T cells plays a detrimental role in experimental Parkinson’s disease in mice. J Int Med Res. 2021;49(4):0300060521998471. https://doi.org/10.1177/030006052199847</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lingappan K. NF-κB in oxidative stress. Curr Opin Toxicol. 2018;7:81-86. https://doi.org/10.1016/j.cotox.2017.11.002</mixed-citation><mixed-citation xml:lang="en">Lingappan K. NF-κB in oxidative stress. Curr Opin Toxicol. 2018;7:81-86. https://doi.org/10.1016/j.cotox.2017.11.002</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Liu B, Shao Y, Fu R. Current research status of HLA in immune‐related diseases. Immun Inflamm Dis. 2021;9(2):340-350. https://doi.org/10.1002/iid3.416</mixed-citation><mixed-citation xml:lang="en">Liu B, Shao Y, Fu R. Current research status of HLA in immune‐related diseases. Immun Inflamm Dis. 2021;9(2):340-350. https://doi.org/10.1002/iid3.416</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):1-9. https://doi.org/10.1038/sigtrans.2017.23</mixed-citation><mixed-citation xml:lang="en">Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):1-9. https://doi.org/10.1038/sigtrans.2017.23</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Lizano P, Lutz O, Ling G, Padmanabhan J, Tandon N, Sweeney J, et al. VEGFA gene variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study. Transl Psychiatry. 2018;8(1):215. https://doi.org/10.1038/s41398-018-0271-y</mixed-citation><mixed-citation xml:lang="en">Lizano P, Lutz O, Ling G, Padmanabhan J, Tandon N, Sweeney J, et al. VEGFA gene variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study. Transl Psychiatry. 2018;8(1):215. https://doi.org/10.1038/s41398-018-0271-y</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Long J, Huang G, Liang W, Liang B, Chen Q, Xie J, et al. The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys. Acta Psychiatr Scand. 2014;130(4):244-256. https://doi.org/10.1111/acps.12296</mixed-citation><mixed-citation xml:lang="en">Long J, Huang G, Liang W, Liang B, Chen Q, Xie J, et al. The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys. Acta Psychiatr Scand. 2014;130(4):244-256. https://doi.org/10.1111/acps.12296</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Lv H, Guo M, Guo C, He K. The interrelationships between cytokines and schizophrenia: a systematic review. Int J Mol Sci. 2024;25(15):8477. https://doi.org/10.3390/ijms25158477</mixed-citation><mixed-citation xml:lang="en">Lv H, Guo M, Guo C, He K. The interrelationships between cytokines and schizophrenia: a systematic review. Int J Mol Sci. 2024;25(15):8477. https://doi.org/10.3390/ijms25158477</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Matern BM, Olieslagers TI, Voorter CE, Groeneweg M, Tilanus MGJ. Insights into the polymorphism in HLA‐DRA and its evolutionary relationship with HLA haplotypes. HLA. 2020;95(2):117-127. https://doi.org/10.1111/tan.13730</mixed-citation><mixed-citation xml:lang="en">Matern BM, Olieslagers TI, Voorter CE, Groeneweg M, Tilanus MGJ. Insights into the polymorphism in HLA‐DRA and its evolutionary relationship with HLA haplotypes. HLA. 2020;95(2):117-127. https://doi.org/10.1111/tan.13730</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Melamud MM, Bobrik DV, Brit PI, Efremov IS, Buneva VN, Nevinsky GA, et al. Biochemical, hematological, inflammatory, and gut permeability biomarkers in patients with alcohol withdrawal syndrome with and without delirium tremens. J Clin Med. 2024;13(10):2776. https://doi.org/10.3390/jcm13102776</mixed-citation><mixed-citation xml:lang="en">Melamud MM, Bobrik DV, Brit PI, Efremov IS, Buneva VN, Nevinsky GA, et al. Biochemical, hematological, inflammatory, and gut permeability biomarkers in patients with alcohol withdrawal syndrome with and without delirium tremens. J Clin Med. 2024;13(10):2776. https://doi.org/10.3390/jcm13102776</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Melincovici CS, Boşca AB, Şuşman S, Mărginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455-467. PMID: 30173249.</mixed-citation><mixed-citation xml:lang="en">Melincovici CS, Boşca AB, Şuşman S, Mărginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455-467. PMID: 30173249.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell JP, Carmody RJ. NF-κB and the transcriptional control of inflammation. Int Rev Cell Mol Biol. 2018;335:41-84. https://doi.org/10.1016/bs.ircmb.2017.07.007</mixed-citation><mixed-citation xml:lang="en">Mitchell JP, Carmody RJ. NF-κB and the transcriptional control of inflammation. Int Rev Cell Mol Biol. 2018;335:41-84. https://doi.org/10.1016/bs.ircmb.2017.07.007</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammadi A, Rashidi E, Amooeian VG. Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. Psychiatry Res. 2018;265:25-38. https://doi.org/10.1016/j.psychres.2018.04.036</mixed-citation><mixed-citation xml:lang="en">Mohammadi A, Rashidi E, Amooeian VG. Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. Psychiatry Res. 2018;265:25-38. https://doi.org/10.1016/j.psychres.2018.04.036</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Mongan D, Ramesar M, Föcking M, Cannon M, Cotter D, et al. Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment. Early Interv Psychiatry. 2020;14(4):385-397. https://doi.org/10.1111/eip.12859</mixed-citation><mixed-citation xml:lang="en">Mongan D, Ramesar M, Föcking M, Cannon M, Cotter D, et al. Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment. Early Interv Psychiatry. 2020;14(4):385-397. https://doi.org/10.1111/eip.12859</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Munkvad I, Fog R, Randrup A. Dopamine and schizophrenia. Clin Physiol. 1981;1:102-107. https://doi.org/10.1111/j.1475-097X.1981.tb00948.x</mixed-citation><mixed-citation xml:lang="en">Munkvad I, Fog R, Randrup A. Dopamine and schizophrenia. Clin Physiol. 1981;1:102-107. https://doi.org/10.1111/j.1475-097X.1981.tb00948.x</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Murphy CE, Lawther AJ, Webster MJ, Asai M, Kondo Y, Matsumoto M, et al. Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines. J Neuroinflammation. 2020;17:1-13. https://doi.org/10.1186/s12974-020-01890-6</mixed-citation><mixed-citation xml:lang="en">Murphy CE, Lawther AJ, Webster MJ, Asai M, Kondo Y, Matsumoto M, et al. Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines. J Neuroinflammation. 2020;17:1-13. https://doi.org/10.1186/s12974-020-01890-6</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Murphy CE, Walker AK, O’Donnell M, Galletly C, Lloyd AR, Liu D, et al. Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases. Transl Psychiatry. 2022;12(1):21. https://doi.org/10.1038/s41398-021-01764-2</mixed-citation><mixed-citation xml:lang="en">Murphy CE, Walker AK, O’Donnell M, Galletly C, Lloyd AR, Liu D, et al. Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases. Transl Psychiatry. 2022;12(1):21. https://doi.org/10.1038/s41398-021-01764-2</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Müller N. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr Bull. 2018;44(5):973-982. https://doi.org/10.1093/schbul/sby024</mixed-citation><mixed-citation xml:lang="en">Müller N. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr Bull. 2018;44(5):973-982. https://doi.org/10.1093/schbul/sby024</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Müller N, Weidinger E, Leitner B, Schwarz MJ. The role of inflammation in schizophrenia. Front Neurosci. 2015;9:372. https://doi.org/10.3389/fnins.2015.00372</mixed-citation><mixed-citation xml:lang="en">Müller N, Weidinger E, Leitner B, Schwarz MJ. The role of inflammation in schizophrenia. Front Neurosci. 2015;9:372. https://doi.org/10.3389/fnins.2015.00372</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Oberstein TJ, Taha L, Spitzer P, Hellstern J, Herrmann M, Kornhuber J, et al. Imbalance of circulating Th17 and regulatory T cells in Alzheimer’s disease: a case control study. Front Immunol. 2018;9:1213. https://doi.org/10.3389/fimmu.2018.01213</mixed-citation><mixed-citation xml:lang="en">Oberstein TJ, Taha L, Spitzer P, Hellstern J, Herrmann M, Kornhuber J, et al. Imbalance of circulating Th17 and regulatory T cells in Alzheimer’s disease: a case control study. Front Immunol. 2018;9:1213. https://doi.org/10.3389/fimmu.2018.01213</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Pantelis C, Yücel M, Wood SJ, McGorry PD, Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust N Z J Psychiatry. 2003;37(4):399-406. https://doi.org/10.1046/j.1440-1614.2003.01193.x</mixed-citation><mixed-citation xml:lang="en">Pantelis C, Yücel M, Wood SJ, McGorry PD, Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust N Z J Psychiatry. 2003;37(4):399-406. https://doi.org/10.1046/j.1440-1614.2003.01193.x</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Peach CJ, Mignone VW, Arruda MA, Alcobia DC, Hill SJ, Kilpatrick LE et al. Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2. Int J Mol Sci. 2018;19(4):1264. https://doi.org/10.3390/ijms19041264</mixed-citation><mixed-citation xml:lang="en">Peach CJ, Mignone VW, Arruda MA, Alcobia DC, Hill SJ, Kilpatrick LE et al. Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2. Int J Mol Sci. 2018;19(4):1264. https://doi.org/10.3390/ijms19041264</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Pillai A, Howell KR, Ahmed AO, Weinberg D, Allen KM, Bruggemann J et al. Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Mol Psychiatry. 2016;21(5):686-692. https://doi.org/10.1038/mp.2015.96</mixed-citation><mixed-citation xml:lang="en">Pillai A, Howell KR, Ahmed AO, Weinberg D, Allen KM, Bruggemann J et al. Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Mol Psychiatry. 2016;21(5):686-692. https://doi.org/10.1038/mp.2015.96</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Pong S, Karmacharya R, Sofman M, Bishop JR, Lizano P. The role of brain microvascular endothelial cell and blood-brain barrier dysfunction in schizophrenia. Complex Psychiatry. 2020;6(1-2):30-46. https://doi.org/10.1159/000511552</mixed-citation><mixed-citation xml:lang="en">Pong S, Karmacharya R, Sofman M, Bishop JR, Lizano P. The role of brain microvascular endothelial cell and blood-brain barrier dysfunction in schizophrenia. Complex Psychiatry. 2020;6(1-2):30-46. https://doi.org/10.1159/000511552</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Rampino A, Annese T, Torretta S, Tamma R, Falcone RM, Ribatti D. Involvement of vascular endothelial growth factor in schizophrenia. Neurosci Lett. 2021;760:136093. https://doi.org/10.1016/j.neulet.2021.136093</mixed-citation><mixed-citation xml:lang="en">Rampino A, Annese T, Torretta S, Tamma R, Falcone RM, Ribatti D. Involvement of vascular endothelial growth factor in schizophrenia. Neurosci Lett. 2021;760:136093. https://doi.org/10.1016/j.neulet.2021.136093</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Requena-Ocaña N, Flores-Lopez M, Papaseit E, García-Marchena N, Ruiz JJ, Ortega-Pinazo J, et al. Vascular endothelial growth factor as a potential biomarker of neuroinflammation and frontal cognitive impairment in patients with alcohol use disorder. Biomedicines. 2022;10(5):947. https://doi.org/10.3390/biomedicines10050947</mixed-citation><mixed-citation xml:lang="en">Requena-Ocaña N, Flores-Lopez M, Papaseit E, García-Marchena N, Ruiz JJ, Ortega-Pinazo J, et al. Vascular endothelial growth factor as a potential biomarker of neuroinflammation and frontal cognitive impairment in patients with alcohol use disorder. Biomedicines. 2022;10(5):947. https://doi.org/10.3390/biomedicines10050947</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Rizzo FR, Musella A, De Vito F, Fresegna D, Bullitta S, Vanni V et al. Tumor necrosis factor and interleukin‐1β modulate synaptic plasticity during neuroinflammation. Neural Plast. 2018;2018:8430123. https://doi.org/10.1155/2018/8430123</mixed-citation><mixed-citation xml:lang="en">Rizzo FR, Musella A, De Vito F, Fresegna D, Bullitta S, Vanni V et al. Tumor necrosis factor and interleukin‐1β modulate synaptic plasticity during neuroinflammation. Neural Plast. 2018;2018:8430123. https://doi.org/10.1155/2018/8430123</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Robinson J, Guethlein LA, Cereb N, Yang SY, Norman PJ, Marsh SG et al. Distinguishing functional polymorphism from random variation in the sequences of &gt;10,000 HLA-A,-B and -C alleles. PLoS Genet. 2017;13(6):e1006862. https://doi.org/10.1371/journal.pgen.1006862</mixed-citation><mixed-citation xml:lang="en">Robinson J, Guethlein LA, Cereb N, Yang SY, Norman PJ, Marsh SG et al. Distinguishing functional polymorphism from random variation in the sequences of &gt;10,000 HLA-A,-B and -C alleles. PLoS Genet. 2017;13(6):e1006862. https://doi.org/10.1371/journal.pgen.1006862</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2(5):e141. https://doi.org/10.1371/journal.pmed.0020141</mixed-citation><mixed-citation xml:lang="en">Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2(5):e141. https://doi.org/10.1371/journal.pmed.0020141</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Sahbaz C, Zibandey N, Kurtulmus A, Duran Y, Gokalp M, Kırpınar I et al. Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia. Psychopharmacology. 2020;237:1861-1871. https://doi.org/10.1007/s00213-020-05504-0</mixed-citation><mixed-citation xml:lang="en">Sahbaz C, Zibandey N, Kurtulmus A, Duran Y, Gokalp M, Kırpınar I et al. Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia. Psychopharmacology. 2020;237:1861-1871. https://doi.org/10.1007/s00213-020-05504-0</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Saoud H, Aflouk Y, Afia AB, Gaha L, Jrad BBH. Association of VEGF-A and KDR polymorphisms with the development of schizophrenia. Hum Immunol. 2022;83(6):528-53. https://doi.org/10.1016/j.humimm.2022.04.003</mixed-citation><mixed-citation xml:lang="en">Saoud H, Aflouk Y, Afia AB, Gaha L, Jrad BBH. Association of VEGF-A and KDR polymorphisms with the development of schizophrenia. Hum Immunol. 2022;83(6):528-53. https://doi.org/10.1016/j.humimm.2022.04.003</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Shivakumar V, Debnath M, Venugopal D, Rajasekaran A, Kalmady SV, Subbanna M et al. Influence of correlation between HLA-G polymorphism and Interleukin-6 (IL6) gene expression on the risk of schizophrenia. Cytokine. 2018;107:59-64. https://doi.org/10.1016/j.cyto.2017.11.016</mixed-citation><mixed-citation xml:lang="en">Shivakumar V, Debnath M, Venugopal D, Rajasekaran A, Kalmady SV, Subbanna M et al. Influence of correlation between HLA-G polymorphism and Interleukin-6 (IL6) gene expression on the risk of schizophrenia. Cytokine. 2018;107:59-64. https://doi.org/10.1016/j.cyto.2017.11.016</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Shivakumar V, Sreeraj VS, Subbanna M, Kalmady SV, Amaresha AC, Narayanaswamy JC et al. Differential impact of interleukin-6 promoter gene polymorphism on hippocampal volume in antipsychotic-naïve schizophrenia patients. Indian J Psychiatry. 2020;62(1):36-42. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_486_19</mixed-citation><mixed-citation xml:lang="en">Shivakumar V, Sreeraj VS, Subbanna M, Kalmady SV, Amaresha AC, Narayanaswamy JC et al. Differential impact of interleukin-6 promoter gene polymorphism on hippocampal volume in antipsychotic-naïve schizophrenia patients. Indian J Psychiatry. 2020;62(1):36-42. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_486_19</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Solleiro-Villavicencio H, Rivas-Arancibia S. Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4+ T cells in neurodegenerative diseases. Front Cell Neurosci. 2018;12:114. https://doi.org/10.3389/fncel.2018.00114</mixed-citation><mixed-citation xml:lang="en">Solleiro-Villavicencio H, Rivas-Arancibia S. Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4+ T cells in neurodegenerative diseases. Front Cell Neurosci. 2018;12:114. https://doi.org/10.3389/fncel.2018.00114</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Stein L, Wise CD. Possible etiology of schizophrenia: Progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science. 1971;171(3975):1032-1036. https://doi.org/10.1126/science.171.3975.103</mixed-citation><mixed-citation xml:lang="en">Stein L, Wise CD. Possible etiology of schizophrenia: Progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science. 1971;171(3975):1032-1036. https://doi.org/10.1126/science.171.3975.103</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Suchanek-Raif R, Raif P, Kowalczyk M, Paul-Samojedny M, Kucia K, Merk W et al. Promoter polymorphisms of TNF-α gene as a risk factor for schizophrenia. Arch Med Res. 2018;49(4):248-254. https://doi.org/10.1016/j.arcmed.2018.09.007</mixed-citation><mixed-citation xml:lang="en">Suchanek-Raif R, Raif P, Kowalczyk M, Paul-Samojedny M, Kucia K, Merk W et al. Promoter polymorphisms of TNF-α gene as a risk factor for schizophrenia. Arch Med Res. 2018;49(4):248-254. https://doi.org/10.1016/j.arcmed.2018.09.007</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Swain SA, Sarangi P, Rattan R, Sahu PK, Lamare AA. A study of nuclear factor-kappa B1 gene polymorphism types in schizophrenia patients and their correlation with disease severity. Cureus. 2022;14(4):e24401. https://doi.org/10.7759/cureus.24401</mixed-citation><mixed-citation xml:lang="en">Swain SA, Sarangi P, Rattan R, Sahu PK, Lamare AA. A study of nuclear factor-kappa B1 gene polymorphism types in schizophrenia patients and their correlation with disease severity. Cureus. 2022;14(4):e24401. https://doi.org/10.7759/cureus.24401</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Tamouza R, Krishnamoorthy R, Leboyer M. Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context. Brain Behav Immun. 2021;91:731-739. https://doi.org/10.1016/j.bbi.2020.09.033</mixed-citation><mixed-citation xml:lang="en">Tamouza R, Krishnamoorthy R, Leboyer M. Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context. Brain Behav Immun. 2021;91:731-739. https://doi.org/10.1016/j.bbi.2020.09.033</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Trovão N, Prata J, VonDoellinger O, Santos S, Barbosa M, Coelho R et al. Peripheral biomarkers for first-episode psychosis—opportunities from the neuroinflammatory hypothesis of schizophrenia. Psychiatry Investig. 2019;16(3):177. https://doi.org/10.30773/pi.2018.12.19.1</mixed-citation><mixed-citation xml:lang="en">Trovão N, Prata J, VonDoellinger O, Santos S, Barbosa M, Coelho R et al. Peripheral biomarkers for first-episode psychosis—opportunities from the neuroinflammatory hypothesis of schizophrenia. Psychiatry Investig. 2019;16(3):177. https://doi.org/10.30773/pi.2018.12.19.1</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Upthegrove R, Khandaker GM. Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia. Neuroinflammation Schizophr. 2020;49-66. https://doi.org/10.1007/7854_2018_88</mixed-citation><mixed-citation xml:lang="en">Upthegrove R, Khandaker GM. Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia. Neuroinflammation Schizophr. 2020;49-66. https://doi.org/10.1007/7854_2018_88</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Volk DW, Moroco AE, Roman KM, Edelson JR, Lewis DA et al. The role of the nuclear factor-κB transcriptional complex in cortical immune activation in schizophrenia. Biol Psychiatry. 2019;85(1):25-34. https://doi.org/10.1016/j.biopsych.2018.06.015</mixed-citation><mixed-citation xml:lang="en">Volk DW, Moroco AE, Roman KM, Edelson JR, Lewis DA et al. The role of the nuclear factor-κB transcriptional complex in cortical immune activation in schizophrenia. Biol Psychiatry. 2019;85(1):25-34. https://doi.org/10.1016/j.biopsych.2018.06.015</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Wang M, Claesson MH. Classification of human leukocyte antigen (HLA) supertypes. Immunoinformatics. 2014;309-317. https://doi.org/10.1007/978-1-4939-1115-8_17</mixed-citation><mixed-citation xml:lang="en">Wang M, Claesson MH. Classification of human leukocyte antigen (HLA) supertypes. Immunoinformatics. 2014;309-317. https://doi.org/10.1007/978-1-4939-1115-8_17</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Wiszniak S, Schwarz Q. Exploring the intracrine functions of VEGF-A. Biomolecules. 2021;11(1):128. https://doi.org/10.3390/biom11010128</mixed-citation><mixed-citation xml:lang="en">Wiszniak S, Schwarz Q. Exploring the intracrine functions of VEGF-A. Biomolecules. 2021;11(1):128. https://doi.org/10.3390/biom11010128</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Wong-Guerra M, Calfio C, Maccioni RB, Rojo LE. Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: A focus on the druggability of current targets. Front Pharmacol. 2023;14:1161850. https://doi.org/10.3389/fphar.2023.1161850</mixed-citation><mixed-citation xml:lang="en">Wong-Guerra M, Calfio C, Maccioni RB, Rojo LE. Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: A focus on the druggability of current targets. Front Pharmacol. 2023;14:1161850. https://doi.org/10.3389/fphar.2023.1161850</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Wu EQ, Shi L, Birnbaum H, Hudson T, Kessler R et al. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychol Med. 2006;36(11):1535-1540. https://doi.org/10.1017/S0033291706008191</mixed-citation><mixed-citation xml:lang="en">Wu EQ, Shi L, Birnbaum H, Hudson T, Kessler R et al. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychol Med. 2006;36(11):1535-1540. https://doi.org/10.1017/S0033291706008191</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Xavier RM, Vorderstrasse A. Genetic basis of positive and negative symptom domains in schizophrenia. Biol Res Nurs. 2017;19(5):559-575. https://doi.org/10.1177/1099800417715907</mixed-citation><mixed-citation xml:lang="en">Xavier RM, Vorderstrasse A. Genetic basis of positive and negative symptom domains in schizophrenia. Biol Res Nurs. 2017;19(5):559-575. https://doi.org/10.1177/1099800417715907</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J, Li J, Xiao K, Zou S, Yan P, Xie X et al. Dynamic changes in human HLA‐DRA gene expression and Th cell subsets in sepsis: Indications of immunosuppression and associated outcomes. Scand J Immunol. 2020;91(1):e12813. https://doi.org/10.1111/sji.12813</mixed-citation><mixed-citation xml:lang="en">Xu J, Li J, Xiao K, Zou S, Yan P, Xie X et al. Dynamic changes in human HLA‐DRA gene expression and Th cell subsets in sepsis: Indications of immunosuppression and associated outcomes. Scand J Immunol. 2020;91(1):e12813. https://doi.org/10.1111/sji.12813</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Yang QQ, Zhou JW. Neuroinflammation in the central nervous system: Symphony of glial cells. Glia. 2019;67(6):1017-1035. https://doi.org/10.1002/glia.23571</mixed-citation><mixed-citation xml:lang="en">Yang QQ, Zhou JW. Neuroinflammation in the central nervous system: Symphony of glial cells. Glia. 2019;67(6):1017-1035. https://doi.org/10.1002/glia.23571</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Yu S, Qu Y, Du Z, Ou M, Lu R, Yuan J et al. The expression of immune related genes and potential regulatory mechanisms in schizophrenia. Schizophr Res. 2024;267:507-518. https://doi.org/10.1016/j.schres.2023.11.007</mixed-citation><mixed-citation xml:lang="en">Yu S, Qu Y, Du Z, Ou M, Lu R, Yuan J et al. The expression of immune related genes and potential regulatory mechanisms in schizophrenia. Schizophr Res. 2024;267:507-518. https://doi.org/10.1016/j.schres.2023.11.007</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Yu YQ, Wang H. Imbalance of Th1 and Th2 cytokines and stem cell therapy in pathological pain. CNS Neurol Disord Drug Targets. 2024;23(1):88-101. https://doi.org/10.2174/1871527322666221226145828</mixed-citation><mixed-citation xml:lang="en">Yu YQ, Wang H. Imbalance of Th1 and Th2 cytokines and stem cell therapy in pathological pain. CNS Neurol Disord Drug Targets. 2024;23(1):88-101. https://doi.org/10.2174/1871527322666221226145828</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Yuan J, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci. 2019;20(1):19-33. https://doi.org/10.1038/s41583-018-0093-1</mixed-citation><mixed-citation xml:lang="en">Yuan J, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci. 2019;20(1):19-33. https://doi.org/10.1038/s41583-018-0093-1</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Fang X, Fan W, Tang W, Cai J, Song L et al. Interaction between BDNF and TNF-α genes in schizophrenia. Psychoneuroendocrinology. 2018;89:1-6. https://doi.org/10.1016/j.psyneuen.2017.12.024</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Fang X, Fan W, Tang W, Cai J, Song L et al. Interaction between BDNF and TNF-α genes in schizophrenia. Psychoneuroendocrinology. 2018;89:1-6. https://doi.org/10.1016/j.psyneuen.2017.12.024</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
